期刊文献+

乙型肝炎病毒表面抗原双顺反子的真核表达载体构建 被引量:2

Construction of a dicistronic expression plasmid vector containing double-valent hepatitis B surface gene
原文传递
导出
摘要 目的利用双顺反子元件构建含 HBsAg双体基因的真核表达载体,以增强 DNA疫苗的免疫疗效。方法我们首先酶切pcDNA3.1-S获得目的基因HBSAg片段,将其克隆到pCI-neo载体得到pCI-S表达载体;另外通过PCR扩增获得目的基因IRES-S并定向克隆到pBluescript K+S载体,相应酶切后再次克隆到pCI-S得到两价HBsAg真核表达载体pCI-S-IRES-S,并进行酶切图谱分析和测序分析。结果pCI-S-IRES—S经相应酶切电泳显示 740 bp和 1350 bp左右的目的基因片段,经测序鉴定, HBsAg与 GeneBank HBsAg adw亚型相符,IRES-S亦无任何变异。结论乙型肝炎表面抗原双体的双顺反子的真核表达载体构建成功,为在真核细胞的高效表达和基因治疗作了必要的准备。 Objective in order to enhance vaccin response, we constructed a dicistronic expression plasmid containing double HBsAg immunogenes. Methods At first, pcDNA3.1 plasmid vector was digested with NheI and EcoRI to get the coding sequence of the small (S) surface Protein of HBV, then cloned into pCI-neo vector and named it pCI-S. By PCR amplification, the product of IRES-S was digested with Sail & BamHI, and cloned into pBluescript IIK+S to generate pBKS-IRES-S vector, then subcloned to the PCI-S plasmid to generate pCI-S-IRES-S, which is a dicistronic plasmid of double value HBsAg genes. Results Two plasmids we constructed were digested with related restriction nucleic enzymes. Sequence analysis of HBsAg and IRES-S gene did not reveal any mutation. Conclusions The construction of dicistronic plasmid of divalue HBsAg immunogenes has been well cloned, which is convenient for further research on cell expression and gene immunization in animals.
出处 《中华肝脏病杂志》 CAS CSCD 2001年第4期206-208,共3页 Chinese Journal of Hepatology
关键词 乙型肝炎病毒 载体 基因重线 双顺反子 HBSAG Hepatitis B virus Vector Gene construction Dicistronic plasmid
  • 相关文献

参考文献2

二级参考文献1

共引文献22

同被引文献16

  • 1Tan JT, Whitmire JK, Ahmed R, et al.4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol, 1999,163:4859-4868.
  • 2DeBenedette MA, Chu NR, Pollok KE, et al. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J Exp Med, 1995,181:985-992.
  • 3Mogi S, Sakurai J, Kohsaka T, et al. Tumour rejection by gene transfer of 4-1BB ligand into a CD80( + ) murine squamous cell carcinoma and the requirements of co-stimulsatory molecules on tumour and host cells.Immunology, 2000,101 : 541-547.
  • 4Guinn BAI DeBenedette MA, Watts TH, et al. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine. J Immunol, 1999, 162:5003-5010.
  • 5Goodwin RG, Din WS, Davis-Smith T, et al. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur J Immunol, 1993,23 : 2631-2641.
  • 6Alderson MR, Smith CA, Tough TW, et al. Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol, 1994,24:2219-2227.
  • 7Zhu G, Flies DB, Tamada K, et al. Progressive depletion of peripheral B lymphocytes in 4-1BB (CD137) ligand/I-Ealpha)-transgenic mice. J Immunol, 2001,167:2671-2676.
  • 8Melero I, Bach N, Hellstrom KE, et al. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway. Eur J Immunol, 1998,28: 1116-1121.
  • 9Melero I, Shuford WW, Newby SA, et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med, 1997,3:682-685.
  • 10Martinet O, Ennekova V, Qiao JQ, et al.Immunomodulatory gene therapy with interleukin 12 and 4-1BB hgand: long- term remission of liver metastases in a mouse model. J Nail Cancer Inst, 2000,92:931-936.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部